secwatch.observer — SEC 8-K summary
======================================

Issuer:     CVRx, Inc. (CVRX)
CIK:        0001235912
Form:       8-K
Filed at:   2025-04-07T23:59:59+00:00
Accession:  0001104659-25-032626
Event type: earnings
Sentiment:  negative
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CVRx preliminary Q1 revenue $12.3M (+15% YoY) but below expectations; cites seasonality, new rep ramp
--------------------------------------------------------------------------------

- Preliminary Q1 2025 revenue ~$12.3M, up 15% YoY from $10.8M.
- U.S. revenue ~$11.2M; European revenue ~$1.1M.
- Active U.S. implant centers 227 (up from 223 at year-end); sales territories reduced to 45.
- Cash and equivalents $102.7M; issued 543,462 shares for $9.5M under ATM in Q1.
- CEO noted revenue fell short due to new sales reps developing and Q1 seasonality; full results due May 8.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1235912/000110465925032626/0001104659-25-032626-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1235912/000110465925032626/tm2511651d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-032626

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer